GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE Uses, Dosage, Side Effects and more

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).

Trade Name GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE
Generic Gastric inhibitory polypeptide
Gastric inhibitory polypeptide Other Names GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share